Balaji Amines Limited (NSE:BALAMINES)
India · Delayed Price · Currency is INR | Market Cap | 58.63B +29.2% |
| Revenue (ttm) | 16.50B +20.9% |
| Net Income | 2.37B +62.4% |
| EPS | 73.10 +62.5% |
| Shares Out | n/a |
| PE Ratio | 24.76 |
| Forward PE | 18.26 |
| Dividend | 11.00 (0.61%) |
| Ex-Dividend Date | Jul 3, 2026 |
| Volume | 68,763 |
| Open | 1,814.00 |
| Previous Close | 1,796.70 |
| Day's Range | 1,803.30 - 1,842.50 |
| 52-Week Range | 968.10 - 2,629.80 |
| Beta | 0.94 |
| Analysts | Hold |
| Price Target | 2,123.00 (+17.29%) |
| Earnings Date | Nov 2, 2026 |
About Balaji Amines
Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India and internationally. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethyl... [Read more]
Financial Performance
In fiscal year 2026, Balaji Amines's revenue was 14.25 billion, an increase of 2.00% compared to the previous year's 13.97 billion. Earnings were 1.67 billion, an increase of 6.14%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for BALAMINES stock is "Hold." The 12-month stock price target is ₹2,123, which is an increase of 17.29% from the latest price.
News
Balaji Amines Transcript: Q2 26/27
Q2 and H1 earnings rose strongly despite lower year-on-year volumes, with sequential EBITDA moderation. Expansion ramp-ups, new product commercialization, and a FY 2028–29 top-line target of INR 3,500–4,000 crore underpin the outlook.
Balaji Amines Quarterly report: Q2 2027
Balaji Amines has published its Q2 2027 quarterly earnings report on November 4, 2026.
Balaji Amines Quarterly report: Q1 2027
Balaji Amines has published its Q1 2027 quarterly earnings report on July 27, 2026.
Balaji Amines reports 14.3% export contribution in FY 2025-26
Balaji Amines Limited has released its Business Responsibility and Sustainability Report for the financial year 2025-26, highlighting its commitment to sustainable practices and stakeholder engagement...
Top gainers in morning trade: balaji amines at ₹2,237.30 up 7.00%, ola electric mobility at ₹47.51 up 6.93%, caplin point laboratories at ₹2,216.00 up 4.97%
The Indian stock market displayed a steady performance this morning, with the Sensex inching up by 0.03% to 73,545.09 and the Nifty 50 rising by 0.09% to 23,144.80. Among the…
Top gainers in morning trade: concord biotech at ₹1,250.40 up 7.22%, balaji amines at ₹2,144.00 up 6.34%, tejas networks at ₹569.65 up 6.02%
The Indian stock market opened to a mixed session with the SENSEX at 73,725.28, down by 1.24%, and the NIFTY 50 at 23,219.50, down by 1.12%. Despite the broader market's…
Top gainers today: newgen at ₹518.10 up 17.35%, balaji amines at ₹2,016.10 up 15.09%, alkyl amines at ₹1,778.70 up 10.91%
The Indian stock market witnessed a positive session today, with the Sensex rising by 0.52% to 74,649.84 and the Nifty 50 climbing 0.43% to 23,483.55. Among the top gainers, Newgen…
Balaji Amines shares rally over 14% today, hit fresh 52-week high of Rs 2,018.70
Balaji Amines share price surged more than 14% in intraday trade on Tuesday, June 2, 2026, with the stock hitting a fresh 52-week high amid strong buying interest from investors.…
Top gainers today: eris lifesciences at ₹1,458.20 up 9.13%, Tata communications at ₹1,775.60 up 7.83%, balaji amines at ₹1,833.30 up 7.29%
The Indian stock market exhibited a positive trend today, with the Sensex rising to 75,318.39, marking a 0.16% increase, and the Nifty 50 climbing to 23,659.00, up by 0.17%. Among…
Balaji Amines’ New DME Plant Could Add Significant Revenue Potential, Marks India’s First Commercial-Scale Facility
Balaji Amines Limited has commissioned India’s first commercial-scale Dimethyl Ether (DME) manufacturing plant, a move that could potentially open up a sizeable new revenue stream for the company as d...
Balaji Amines launches India's first DME plant with 1,00,000 TPA capacity
Balaji Amines Limited has successfully commenced commercial production at its Dimethyl Ether (DME) plant in Solapur, Maharashtra, marking a significant milestone as India's first DME manufacturing fac...
Balaji Amines Transcript: Q4 25/26
FY26 revenue, EBITDA and PAT increased, with Q4 EBITDA margin reaching 25%. Growth projects underpin guidance, while volatile raw-material costs, DME transport approval and slower battery-sector uptake remain key uncertainties.
Balaji Amines Annual report: Q4 2026
Balaji Amines has published its Q4 2026 annual report on May 18, 2026.
Balaji Amines Quarterly report: Q4 2026
Balaji Amines has published its Q4 2026 quarterly earnings report on May 18, 2026.
Balaji Amines Slides: Q4 2026
Balaji Amines has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.
Top gainers today: balaji amines at ₹1,623.40 up 19.99%, saregama India at ₹384.55 up 14.77%, NLC India at ₹370.90 up 13.88%
The Indian stock market witnessed a positive trend today, with the Sensex rising by 1.06% to 75,398.72 and the Nifty 50 increasing by 1.18% to 23,689.60. Among the top gainers,…
Balaji Amines reports consolidated Q4FY26 revenue of Rs 403 crore
Balaji Amines Limited, a prominent manufacturer of aliphatic amines and speciality chemicals in India, has announced its audited financial results for the quarter and year ended 31st March 2026. The…
Top gainers in morning trade: balaji amines at ₹1,623.40 up 19.99%, NLC India at ₹383.90 up 17.87%, godrej industries at ₹1,219.35 up 13.62%
In the morning session of 14 May 2026, the Indian stock market displayed a positive trend with the Sensex inching up by 0.04% to 74,639.85 and the Nifty 50 rising…
Why Balaji Amines shares hit 20% upper circuit today? Explained
Shares of Balaji Amines surged 20% to hit the upper circuit in morning trades after the specialty chemicals maker reported a strong set of earnings for the quarter ended March…
Balaji Amines declares Rs 11 per share dividend following strong financial results
Balaji Amines has announced a final dividend of ₹11 per equity share, representing a 550% payout on the face value of ₹2 per share. This proposal is subject to approval…
Top gainers today: valor estate at ₹124.28 up 20.00%, balaji amines at ₹1,455.50 up 9.14%, HFCL at ₹126.04 up 8.63%
Indian markets maintained a positive trajectory today, with the Sensex rising to 77,269.40, up 0.46%, and the Nifty 50 climbing to 24,119.30, up 0.51%. Despite some profit booking in the…
Balaji Amines resumes partial production as ammonia supply stabilises
Balaji Amines has announced a partial resumption of its production activities following improvements in the global ammonia supply chain. The company had previously placed its plants in a partially non...
Balaji Amines shares fall over 3% amid ammonia supply disruption linked to Middle East conflict
Shares of Balaji Amines Ltd declined more than 3% in early trade after the company reported disruptions in procuring ammonia, a critical raw material used across its production processes. The…
Balaji Amines faces operational disruptions due to ammonia shortage
Balaji Amines is experiencing significant logistics disruptions in procuring ammonia, a key raw material for its production processes. The ongoing conflict in the Middle East has disrupted global ship...
Balaji Amines cancels scheduled plant visit and management meet on 13th March
Balaji Amines has announced the cancellation of its scheduled plant visit and management meet with investors and analysts, which was initially planned for 13th March 2026. The company cited unavoidabl...